Regenerative Therapeutics Research

Advancing Regenerative Therapies Through Research and Education

The Rongxiang Xu, MD, Center for Regenerative Therapeutics also conducts collaborative bench-to-bedside research with investigators worldwide, and educates physicians and scientists internationally about new therapies and the management of the problems they treat. The center also sponsors an annual lecture by a world-renowned expert.

The center seeks to build strong partnerships, promote collaborations, and solve currently intractable clinical problems. Fostering closer connections between bench and bedside, ensuring the highest quality preclinical research, and accelerating clinical trials of promising technologies.

The center is guided by an Advisory Board and receives input from a Scientific Advisory Board comprised of leaders from within and outside of the Harvard community.

The Xu Center trains physicians worldwide in the management of severe health problems, such as acute and chronic wounds, diabetes-related lower extremity problems, and burns, and collaborates with scientists in the development of innovative new treatments for these conditions.

The Xu Center encourages collaborations with other nonprofit organizations worldwide that share our mission. These collaborations will include the development of courses that will train physicians and scientists from around the world, with a particular emphasis in developing counties.

In addition, the Xu Center will participate in and support local educational activities, including meetings that focus on regenerative medicine and wound healing.

Legacy and Impact of Rongxiang Xu, MD

Rongxiang Xu, MD (1958-2015), graduated from the Qingdao Medical College in China. Trained as a surgeon, Dr. Xu witnessed the suffering of burn patients treated with conventional therapy and was determined to develop a more effective, less painful approach. He developed new topical therapies based on botanical drugs that helped to restore the physiological structure and function of the skin, thereby dramatically reducing pain, illness, and death.

Dr. Xu’s significant contributions advanced wound therapy, saved lives, and dramatically improved the quality of life for countless patients around the world.

Over the past three decades, Dr. Xu’s research in tissue repair and regeneration led to multiple U.S. patents and the growth of his successful multi-national company, MEBO International. His scientific achievements have been acknowledged by U.S. Presidents Barack Obama, Bill Clinton, and George H. W. Bush. The Chinese government honored Dr. Xu for his numerous contributions with a commemorative stamp with his image.

Dr. Xu’s interest in the translation of his work to a broad group of patients was further realized through a longstanding collaboration with Aristidis Veves, MD, DSc, in the Department of Surgery at BIDMC. In recognition of Dr. Veves’s international leadership in the field of regenerative therapeutics and wound healing, he was nominated to serve as the first Rongxiang Xu, MD Professor of Surgery at Harvard Medical School.

Leadership

In recognition of his international leadership in the field of regenerative therapeutics and wound healing, Aristidis Veves, MD, DSc, serves as the first Rongxiang Xu, MD, Professor of Surgery at Harvard Medical School, and Director of the BIDMC Rongxiang Xu, MD, Center for Regenerative Therapeutics. Email Dr. Veves with any questions.